1-3 of 3
Christophe Hirtz
Close
Sort by
Journal Articles

Epigenetic Modifiers MMSET and EZH2 Physically Interact and Cooperate to Support Multiple Myeloma Pathophysiology

Emmanuel Varlet, Elina Alaterre, Morgane Thomas, Hugues De Boussac, Laure Vincent, Guillaume Cartron, Charles Herbaux, Caroline Bret, Laurie Herviou, Anne Marie Martinez, Christophe Hirtz, Aurore Attina, Jerome Vialaret, Giacomo Cavalli, Jerome Moreaux, Sara Ovejero
Journal: Blood
Blood (2023) 142 (Supplement 1): 1964.
https://doi.org/10.1182/blood-2023-181018
Published: 2023
Journal Articles

Targeting Iron Homeostasis As a Therapeutic Strategy in Multiple Myeloma

Sara ovejero-Merino, Julie Devin, Tatiana Cañeque, Laura Alibert, Guilhem Requirand, Nicolas Robert, Alizée Steer, Amelie Machura, Christophe Hirtz, Angélique Bruyer, Laure Vincent, Guillaume Cartron, Charles Herbaux, Raphael Rodriguez, Caroline Bret, Jerome Moreaux
Journal: Blood
Blood (2022) 140 (Supplement 1): 9980–9981.
https://doi.org/10.1182/blood-2022-163252
Published: 2022
Journal Articles

CD200 Is a Potent New Growth Factor in Multiple Myeloma through IGF-1R Interaction

Angélique Bruyer, MSc, Nicolas Robert, Stéphanie Boireau, Christophe Hirtz, Laurent Tiers, Laure Vincent, Guillaume Cartron, Dirk Hose, MD, Anja Seckinger, Bernard Klein, PhD, Jerome Moreaux, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3045.
https://doi.org/10.1182/blood.V130.Suppl_1.3045.3045
Published: 2017